THC
17.3–20.2%
CBD
0.3%
A hybrid strain designed for therapeutic relief, with calming effects and an earthy taste that helps manage discomfort and promote relaxation.
No flavor data specific to Eff Cancer has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
Explore More
Terpene Fingerprint
Relative terpene levels from lab and source data
THC in this profile
20.2% THC
About Eff Cancer
As a hybrid designed for calm and relaxation, this strain offers a gentle, soothing embrace with its 20.2% THC, making it particularly effective for those battling nausea and pain. Key terpenes including Caryophyllene, Linalool, and Humulene deliver an earthy, herbal, and sweet taste that enhances its therapeutic qualities, providing a comforting respite without overpowering intensity. Though the breeder is unknown, Eff Cancer is notable for its straightforward, compassionate effects that focus on physical relief, earning it a special place in medical users' routines.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Eff Cancer
Is Eff Cancer an Indica, Sativa, or Hybrid?
Eff Cancer is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Eff Cancer?
Eff Cancer: 20.2% THC and 0.3% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.
What are the common effects of Eff Cancer?
Our data sources report these effects for Eff Cancer: calm, relaxed. Individual experiences vary.
What does Eff Cancer taste and smell like?
Our data sources list terpenes such as Caryophyllene, Humulene, Linalool for Eff Cancer.
If You Like Eff Cancer, Try...
Shared reported terpene or flavor notes; effects may differ
